Daratumumab in combination with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma (review of TA573): a single technology appraisal

Ribeiro, Inês, Maund, Emma, Kalita, Neelam, Scott, David Alexander and Picot, Jo (2023) Daratumumab in combination with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma (review of TA573): a single technology appraisal (Health Technology Assessment) National Institute for Health and Care Excellence 110pp.

Record type: Monograph (Project Report)

Abstract

In this report we provide a critique of the CDF review company’s submission (CS) to NICE for the review of TA5731 on the clinical effectiveness and cost effectiveness of daratumumab with bortezomib and dexamethasone (DBd) for treating relapsed or refractory multiple myeloma following the period of managed access within the Cancer Drugs Fund (CDF).

This record has no associated files available for download.

More information

Published date: 6 June 2023

Related URLs:

https://www.nice.org.uk/guidan...7/evidence

Identifiers

Local EPrints ID: 484625

URI: http://eprints.soton.ac.uk/id/eprint/484625

PURE UUID: 31bffad4-fad7-4e55-a1a2-5da2192c94b1

ORCID for Inês Ribeiro:

orcid.org/0000-0001-8464-4513

ORCID for Emma Maund:

orcid.org/0000-0002-3998-6669

ORCID for Neelam Kalita:

orcid.org/0000-0002-0973-0160

ORCID for David Alexander Scott:

orcid.org/0000-0001-6475-8046

ORCID for Jo Picot:

orcid.org/0000-0001-5987-996X

Catalogue record

Date deposited: 17 Nov 2023 18:09

Last modified: 11 Sep 2024 02:26

Export record

Share this record

Share this on Facebook Share this on Twitter Share this on Weibo

Contributors

Author: Inês Ribeiro

Author: Emma Maund

Author: Neelam Kalita

Author: David Alexander Scott

Author: Jo Picot

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Library staff additional information